Showing results (21-30 of 230) with videos related to
Sort By:
Pageof 23
Oncology (Williston Park, N.Y.)|October 1, 1989
Signs, symptoms, and significance of paraneoplastic neurological syndromesJ HildebrandJournal of the National Cancer Institute|April 1, 1981
Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agentT E Spiro, M Socquet, A Delforge, et al.Bollettino Dell'Istituto Sieroterapico Milanese|July 31, 1978
Usefulness of cell kinetics for staging of chronic myeloid leukemia?P Stryckmans, E Ronge-Collard, L Debusscher, et al.Cancer Treatment Reports|January 1, 1981
A review of studies of the EORTC brain tumor groupJ HildebrandDrugs Under Experimental and Clinical Research|January 1, 1986
Radiotherapy and chemotherapy of malignant brain gliomasJ HildebrandActa Neurochirurgica|January 1, 1993
Indications for stereotactically-aided differential diagnosis: the neurologist's viewJ HildebrandJournal of Neuro-Oncology|August 8, 1998
Prophylaxis and treatment of leptomeningeal carcinomatosis in solid tumors of adulthoodJ HildebrandExperimental Hematology|January 1, 1994
Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cellsL Lagneaux, A Delforge, R Snoeck, et al.Blood|October 15, 1993
Excessive production of transforming growth factor-beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 productionL Lagneaux, A Delforge, C Dorval, et al.Pageof 23